The Roche Group has issued its first quarter report showing that global sales rose by 3% to CHF 11.8 billion (€11.3 billion) from a year earlier. However, the underlying performance was affected by a 6.8% rise of the dollar against the Swiss franc and a 12.1% decline of the euro against the franc.
